Recent advances in targeted therapy for Ewing sarcoma [version 1; referees: 2 approved] by Kathleen I. Pishas, Stephen L. Lessnick

Get full text

Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma. by Davis T Weaver, Kathleen I Pishas, Drew Williamson, Jessica Scarborough, Stephen L Lessnick, Andrew Dhawan, Jacob G Scott

Get full text

Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein by Emily R. Theisen, Julia Selich-Anderson, Kyle R. Miller, Jason M. Tanner, Cenny Taslim, Kathleen I. Pishas, Sunil Sharma, Stephen L. Lessnick

Get full text

High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma by Kathleen I. Pishas, Karla J. Cowley, Marta Llaurado-Fernandez, Hannah Kim, Jennii Luu, Robert Vary, Nikola A. Bowden, Ian G. Campbell, Mark S. Carey, Kaylene J. Simpson, Dane Cheasley

Get full text

Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing by Deepak N. Subramanian, Maia Zethoven, Kathleen I. Pishas, Evanny R. Marinović, Simone McInerny, Simone M. Rowley, Prue E. Allan, Lisa Devereux, Dane Cheasley, Paul A. James, Ian G. Campbell

Get full text

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression by Dane Cheasley, Marta Llaurado Fernandez, Martin Köbel, Hannah Kim, Amy Dawson, Joshua Hoenisch, Madison Bittner, Derek S. Chiu, Aline Talhouk, C. Blake Gilks, Madawa W. Jayawardana, Kathleen I. Pishas, Anne-Marie Mes-Masson, Diane Provencher, Abhimanyu Nigam, Neville F. Hacker, Kylie L. Gorringe, Ian G. Campbell, Mark S. Carey

Get full text